Central and Opposing Effects of IGF-I and IGF-Binding Protein-3 on Systemic Insulin Action
Open Access
- 1 October 2006
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 55 (10), 2788-2796
- https://doi.org/10.2337/db06-0318
Abstract
IGF-I is recognized as an insulin sensitizer at the liver and muscle, while recent evidence suggests that IGF-binding protein (IGFBP)-3 acts as an insulin antagonist. As there is a paucity of IGF-I receptors in the liver and as the IGF-IGFBP system in the central nervous system is emerging as physiologically relevant, we examined whether the effects of IGF-I and IGFBP-3 on insulin action are mediated through central mechanisms. Intracerebroventricular (ICV) infusion of IGF-I during the insulin clamp (3 mU · kg−1 · min−1) resulted in significant improvement in hepatic insulin action (50%, P < 0.05). In contrast, ICV infusion of IGFBP-3 significantly impaired insulin action at the liver (45% increase in hepatic glucose production, P < 0.01). While IGF-I marginally increased peripheral glucose uptake, IGFBP-3 significantly decreased peripheral glucose uptake (∼30%, P < 0.01). As the nuclear localization signal mutant IGFBP-3, which has a normal affinity to IGFs but binds other IGFBP-3 partners poorly and fails to normally internalize, has reduced central activity on metabolism, we conclude that the effects of IGFBP-3 on the hypothalamus involve activity mediated by interfacing with other molecules in addition to IGFs. Marked, opposing, and independent physiological effects of IGF-I and IGFBP-3 through central mechanisms may have implications on potential strategies in specific modulation of peripheral insulin action.Keywords
This publication has 50 references indexed in Scilit:
- Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and menAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational studyThe Lancet, 2002
- Insulin-like Growth Factor-binding Protein-3 Activates a Phosphotyrosine PhosphatasePublished by Elsevier BV ,2002
- Direct Functional Interactions between Insulin-like Growth Factor-binding Protein-3 and Retinoid X Receptor-α Regulate Transcriptional Signaling and ApoptosisJournal of Biological Chemistry, 2000
- Phasic synaptic remodeling of the rat arcuate nucleus during the estrous cycle depends on insulin-like growth factor-I receptor activationJournal of Neuroscience Research, 1999
- Distribution and levels of insulin-like growth factor I mRNA across the life span in the Brown Norway×Fischer 344 rat brainBrain Research, 1998
- Metabolic Effects of Insulin-Like Growth Factor I in Normal HumansHormone Research, 1994
- Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretionEndocrinology, 1992
- Acute and long‐term effects of insulin‐like growth factor I on glucose transporters in muscle cells Translocation and biosynthesisFEBS Letters, 1992
- CHANGES IN CIRCULATING SOMATOMEDIN-C LEVELS IN BROMOCRIPTINE-TREATED ACROMEGALYClinical Endocrinology, 1982